Weight Loss Drug Empatic Meets Study Goals, Diet and Weight Loss
The weight loss drug Empatic, developed by Orexigen Therapeutics, Inc., met its main goals in its second Phase IIb clinical trial, which means researchers can now continue to a Phase III clinical tria.
More: continued here
